Pharmaceutical leaders call for greater investment in health systems

Aid agencies must invest more in strengthening health systems and infrastructure to avoid the catastrophic consequences of multidrug-resistant tuberculosis, U.K. parliamentarians have warned. But prevention is not only dependent on drug development, senior figures in the pharmaceutical sector have told Devex.

About the author

  • Gabriella Jóźwiak

    Gabriella Jóźwiak is an award-winning journalist based in London. Her work on issues and policies affecting children and young people in developing countries and the U.K. has been published in national newspapers and magazines. Having worked in-house for domestic and international development charities, Jóźwiak has a keen interest in organizational development, and has worked as a journalist in several countries across West Africa and South America.